Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: A phase II study

Neoplasma

Volumn 52, Issue 6, 2005, Pages 497-501

  Mardiak, J ^a   Salek T ^a   Sycova Mila Z ^a   Obertova J ^a   Hlavata Z ^a   Mego, M ^a   Reckova M ^a   Koza, I ^a  

^a CANCER RESEARCH INSTITUTE   (Slovakia)

Author keywords

Cisplatin; Germ cell tumors; Ifosfamide; Paclitaxel; Salvage treatment

Indexed keywords

CISPLATIN; DEXAMETHASONE; DITHIADEN; IFOSFAMIDE; MESNA; PACLITAXEL; RANITIDINE;

ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; GERM CELL TUMOR; GRANULOCYTOPENIA; HUMAN; LIVER TOXICITY; MALE; MUCOSA INFLAMMATION; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; RELAPSE; THROMBOCYTOPENIA; VOMITING;

EID: 29144451356     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. AMATO RJ, PROW DM. Paclitaxel-based chemotherapy for patients with refractory or relapsed nonseminomatous germ cell tumors. Urol Oncol 2000; 1: 134-138.
2. BANIEL J, FOSTER RS, GONIN R, MESSEMER JE, DONOHUE JP et al. Late relapse of testicular cancer. J Clin Oncol 1995; 13: 1170-1176.
3. BOLIS G, SCARFONE G, POLVERINO G, RASPAGLIESI F, TATEO S et al. Paclitaxel 175 or 225 mg per meters squared with carboplatin in advanced ovarian cancer: a randomized trial. J Clin Oncol 2004; 22: 686-690.
4. BOKEMEYER C, BEYER J, METZNER B, RUTHER U, HARSTRICK A et al. Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. Ann Oncol 1996; 7: 31-34.
5. DONADIO AC, SHEINFELD J, BACIK J, MAZUMDAR M, MARION S et al. Paclitaxel, ifosfamid, and cisplatin (TIP): An effective second-line therapy for patients (pts) with relapsed germ cell tumors (GCT). Proc Amer Soc Clin Oncol 2001; 22: 382.
6. EINHORN LH. Clinical trials in testicular cancer. Cancer 1993; 71: 3182-3184.
7. EINHORN LH. Treatment of testicular cancer: A new and improved model. J Clin Oncol 1990; 8: 1777-1781.
8. FOSSA SD, OLIVER RT, STENNING SP, HORWICH A, WILKINSON P et al. Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy. Eur J Cancer 1997; 33: 1380-1387.
9. GERL A, CLEMM C, SCHMELLER N, HARTENSTEIN R, LAMERZ R et al. Prognosis after salvage treatment for unselected male patients with germ cell tumours. Br J Cancer 1995; 72: 1026-1032.
10. JOSEFSEN D, OUS S, HOIE J, STENWIG AE, FOSSA SD. Salvage treatment in male patients with germ cell tumours. Br J Cancer 1993; 67: 568-572.
11. 2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG). Ann Oncol 2000; 11: 799-805.
12. LOEHRER PJ, WILLIAMS SD, NICHOLS CR, EINHORN LH. Clinical trials with ifosfamide: The Indiana University experience. Semin Oncol 1992; 19: 35-39.
13. MILLER AB, HOODGSTATEN B, STAQUET M, WINKLER A. Reporting results of cancer traetment. Cancer 1981; 47: 207-211.
14. MOTZER RJ, BAJORIN DF, SCHWARTZ LH, HUTTER HS, BOSL GJ et al. Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors. J Clin Oncol 1994; 12: 2277-2283.
15. MOTZER PJ, GELLER NL, TAN CC, HERR H, MORSE M et al. Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989). Cancer 1991; 67: 1305-1310.
16. MOTZER RJ, SHEINFELD J, MAZUMDAR M, BAINS M, MARIANI T et al. Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer. J Clin Oncol 2000; 18: 2413-2418.
17. SANDLER AB, CHRISTOU A, FOX S, WILLIAMS SD, NICHOLS CR et al. A phase II trial of paclitaxel in refractory germ cell tumors. Cancer 1998; 82: 1381-1386.
18. WILLIAMS SD, EINHORN LH, GRECO FA, OOLDHAM R, FLETCHER R. W-16-213 salvage therapy for refractory germinal neoplasm. Cancer 1980; 46: 2154-2158.
19. WINNER E, MORROW W, OSBORNE CK, HARRIS JR. Malignant tumors of the breast. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology, 6th edition. Philadelphia, PA: Lippincott Williams & Wilkins 2001; 1699-1717.